Literature DB >> 4052630

Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes.

J Ross, T D Sullivan.   

Abstract

The turnover rates of beta and gamma globin messenger RNAs and of beta and gamma globin protein synthesis in human reticulocytes have been measured. Our goal was to determine whether beta globin mRNA is significantly more stable than gamma globin mRNA during the final stages of erythroid cell maturation. Such a result could explain the reported increase in the beta-gamma protein synthetic ratio during erythroid maturation. As determined by molecular hybridization and cell-free translation assays, the half-lives of both mRNAs are 20 to 29 hours in adult and neonatal reticulocytes. Protein synthetic capacity in intact cells decays with a half-life of six to eight hours, but beta protein synthesis declines at the same rate as gamma. Therefore, the changing ratio of fetal to adult hemoglobin synthesis during late erythroid maturation does not result from differences in mRNA turnover rates or changes in translation efficiencies. These data, coupled with those obtained with immature erythroid cells (Farquhar et al, Dev Biol 85: 403, 1981), suggest that, during erythroid maturation, the gamma-beta globin protein synthesis ratio declines because gamma gene transcription ceases earlier than beta gene transcription. Our results also indicate that the protein synthetic machinery, not the quantity of mRNA, becomes rate-limiting for globin production in cultured reticulocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052630

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Identification of an erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage.

Authors:  Z Wang; M Kiledjian
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

Review 2.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  5' untranslated sequences modulate rapid mRNA degradation mediated by 3' AU-rich element in v-/c-fos recombinants.

Authors:  N Roy; G Laflamme; V Raymond
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

4.  AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cells.

Authors:  Sebastiaan van Zalen; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

5.  AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein.

Authors:  Sebastiaan van Zalen; Alyssa A Lombardi; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Mech Dev       Date:  2015-02-23       Impact factor: 1.882

6.  A study on postmortem stability of vasopressin messenger RNA in rat brain compared with those in total RNA and ribosomal RNA.

Authors:  I Noguchi; H Arai; R Iizuka
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  A nucleolin-binding 3' untranslated region element stabilizes beta-globin mRNA in vivo.

Authors:  Yong Jiang; Xiang-Sheng Xu; J Eric Russell
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Dynamic posttranscriptional regulation of epsilon-globin gene expression in vivo.

Authors:  Zhenning He; J Eric Russell
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

9.  Chapter 3. Assays of adenylate uridylate-rich element-mediated mRNA decay in cells.

Authors:  Riza M Ysla; Gerald M Wilson; Gary Brewer
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

10.  The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells.

Authors:  Darby L Thomas; Martin Lock; Janice M Zabolotny; Bangalore R Mohan; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.